The UK government is preparing to publish its long-awaited response to the 2016 Accelerated Access Review, an industry-inspired set of proposals for identifying and speeding access to innovative drugs and other medical products that are likely to be of most benefit to patients while ensuring costs are kept at manageable levels.
The government said in July this year that it was still preparing its “ambitious and transformative” response on how to...







